MEDICAMEN BIOTECH
|
The Current P/E Ratio of MEDICAMEN BIOTECH is 35.71.
| Share Price | ₹263.7 | Oct 21,2026 |
| Market Cap | ₹358.6 Cr | |
| Earnings-TTM | ₹10.0 Cr | TTM-Consolidated Results |
| Price/Earnings | 35.71x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of MEDICAMEN BIOTECH
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹358.6 Cr] as on Oct 21,2026
(/) Earnings [ ₹10.0 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 35.71x ]
Thus, for MEDICAMEN BIOTECH , the investors are currently willing to pay 35.71 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of MEDICAMEN BIOTECH !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of MEDICAMEN BIOTECH over the last five years.
Historical PE (Price/Earnings) ratio chart of MEDICAMEN BIOTECH
PE Ratio Performance Analysis for MEDICAMEN BIOTECH
- MEDICAMEN BIOTECH 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 61.52x.
- MEDICAMEN BIOTECH 's operated at median p/e ratio of 53.78x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, MEDICAMEN BIOTECH 's p/e ratio peaked in Mar2025 at 93.43x.
- MEDICAMEN BIOTECH 's p/e ratio hit its five-year low in Mar2024 of 51.31x.
How does MEDICAMEN BIOTECH 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| MEDICAMEN BIOTECH | 10.04 | 35.71 | 358.6 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 12,172.70 | 34.40 | 418,684.0 |
| DIVIS LABORATORIES LTD | 2,925.00 | 83.04 | 242,904.0 |
| TORRENT PHARMACEUTICALS LTD | 2,156.00 | 79.88 | 172,213.0 |
| CIPLA LTD | 3,364.84 | 31.54 | 106,138.0 |
| DR REDDYS LABORATORIES LTD | 3,169.30 | 32.60 | 103,304.0 |
| MANKIND PHARMA LTD | 2,055.11 | 45.84 | 94,215.6 |
| LUPIN LTD | 5,551.01 | 16.12 | 89,491.6 |
| ZYDUS LIFESCIENCES LTD | 4,492.20 | 24.81 | 111,451.0 |
| AUROBINDO PHARMA LTD | 3,712.74 | 24.43 | 90,693.9 |
| LAURUS LABS LTD | 1,090.76 | 99.67 | 108,711.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs MEDICAMEN BIOTECH 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 16.12x |
| Max industry PE | 99.67x |
| Median industry PE | 34.40x |
| Average industry PE | 46.18x |
You may also like the below Video Courses